Organoidsciences Ltd. (KOSDAQ:476040)
25,600
-2,850 (-10.02%)
At close: Mar 9, 2026
Organoidsciences Market Cap
Organoidsciences has a market cap or net worth of 168.60 billion as of March 9, 2026.
Market Cap
168.60B
Enterprise Value
153.53B
Revenue
2.55B
Ranking
n/a
PE Ratio
n/a
Stock Price
25,600.00
Market Cap Chart
Since May 9, 2025, Organoidsciences's market cap has decreased from 208.19B to 168.60B, a decrease of -19.02%. That is a compound annual growth rate of -22.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 168.60B | -33.10% |
| Dec 30, 2025 | 252.02B | 21.05% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OPTUS Pharmaceutical | 186.35B |
| Vivozon Pharmaceutical | 196.71B |
| GREEN CROSS WellBeing | 168.05B |
| High Tech Pharm | 166.94B |
| NOVAREX | 225.53B |
| Kyung Dong Pharmaceutical | 148.18B |
| DongKoo Bio & Pharma | 145.49B |
| DAE HWA Pharmaceutical | 250.31B |